Helen Kang

Helen Kang is a PhD student in the Computational and Systems Biology program at Massachusetts Institute of Technology (MIT). She aspires to use computational and experimental methods to uncover key cellular processes that drive cardiovascular disease. Prior to joining MIT, Helen studied the genetic underpinnings of coronary artery disease (CAD) in Dr. Jesse Engreitz’s laboratory at Stanford. She created an approach, Variant-to-Gene-to-Program (V2G2P), to systematically study CAD and to dissect new disease mechanisms. Helen obtained Bachelor of Arts in applied mathematics and molecular and cellular biology from University of California, Berkeley. Outside of research, Helen enjoys traveling across the globe, hiking in the nature, exploring museums, and listening to classical music.